Doctors tie-up with Nobel laureate Abhijit Banerjee to launch app to aid rural health

Abhijit Banerjee and doctors are trying to determine whether technology can help quacks provide correct guidance to patients; Pilot project initiated in Bengal 
 

Published: 24th October 2019 11:09 AM  |   Last Updated: 05th November 2019 07:28 PM   |  A+A-

Srinjoy Bose (R), assistant general secretary and Debasish Dutta (L), finance secretary, Mohun Bagan Athletic Club meet Nobel laureate Abhijit Banerjee to offer him lifetime membership of the club, in Kolkata on Wednesday | Pti

Express News Service

NEW DELHI:  Doctors collaborating with the Nobel laureate economist Abhijit Banerjee have set out to determine whether technology — a decision support system on mobile phones — could help unqualified rural healthcare practitioners or quacks provide correct guidance to patients. While a pilot project is already on with quacks in Purulia, Birbhum and 24 North Parganas of West Bengal, a randomised controlled trial is on the anvil with about 1,000 informal healthcare providers in the same three districts.

Kolkata-based public health organisation 'Liver Foundation', New Delhi-based Raxa Health and Abhijit Banerjee have come together for a project that will equip quacks with an app with components of artificial intelligence and machine learning.

A prior study co-designed by Banerjee between 2010-2015, to assess what impact quacks have on healthcare outcome in a given area had shown that 72 training classes over nine months had helped improve the ability of unqualified practitioners to manage three limited conditions — diarrhoea, chest pain and respiratory distress.

Findings of the study, that was later also supported by the state government, were published in the journal, Science.“We are now looking to determine whether human training can be replaced with the use of technology and if it’s helpful what’s the degree of usefulness,” said Partha Sarathi Mukherjee, director of Liver Foundation.

Surajit Nundy of Raxa Health, who has designed the app for the planned trial, says that while the project has not received the full funding yet, they hope the project is fully funded soon.“It’s an important project to assess how technology can help in telling informal healthcare providers the dos and don’ts, diagnosing simple health issues and improving referrals for serious medical conditions,” said Nundy.

The trial once started, will take around three years to determine outcomes.

Banerjee, an Indian-born American professor at Massachusetts Institute of Technology, has won the Nobel Prize in economics for 2019 jointly with French-American Esther Duflo, his wife and Michael Kremer of Harvard University for “experimental approach to alleviating global poverty”.

He is known for carrying out randomised controlled trials in the fields of education and health.

Some shopping

In Kolkata, Banerjee visited a reputed fabrics outlet, known for its collection of ethnic dresses, and stayed there for about half-an-hour. He is slated to leave the city early on Thursday.
 

Stay up to date on all the latest Nation news with The New Indian Express App. Download now
(Get the news that matters from New Indian Express on WhatsApp. Click this link and hit 'Click to Subscribe'. Follow the instructions after that.)

Comments

Disclaimer : We respect your thoughts and views! But we need to be judicious while moderating your comments. All the comments will be moderated by the newindianexpress.com editorial. Abstain from posting comments that are obscene, defamatory or inflammatory, and do not indulge in personal attacks. Try to avoid outside hyperlinks inside the comment. Help us delete comments that do not follow these guidelines.

The views expressed in comments published on newindianexpress.com are those of the comment writers alone. They do not represent the views or opinions of newindianexpress.com or its staff, nor do they represent the views or opinions of The New Indian Express Group, or any entity of, or affiliated with, The New Indian Express Group. newindianexpress.com reserves the right to take any or all comments down at any time.

flipboard facebook twitter whatsapp